P Venge

Author PubWeight™ 297.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Eosinophilic inflammation in asthma. N Engl J Med 1990 8.05
2 Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000 4.35
3 Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985 3.77
4 Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation 1996 2.91
5 Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 2001 2.87
6 Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 1986 2.41
7 Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood 1974 2.22
8 Lipocalins as biochemical markers of disease. Biochim Biophys Acta 2000 2.08
9 Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004 2.03
10 Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 1984 1.75
11 Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med 1999 1.69
12 Radioimmunoassay of human eosinophil cationic protein. Br J Haematol 1977 1.68
13 Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin Exp Allergy 1993 1.65
14 Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group. Eur Heart J 1997 1.65
15 Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med 2000 1.58
16 Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab Invest 1977 1.57
17 Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest 1980 1.56
18 The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin Exp Allergy 1999 1.55
19 Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest 1995 1.51
20 Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta 2011 1.49
21 The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer. Br J Haematol 1997 1.47
22 Granulocytes and their secretory products, myeloperoxidase and eosinophil cationic protein, in bronchoalveolar lavage fluids from two lung lobes in normal subjects. Eur Respir J 1991 1.45
23 Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut 2002 1.45
24 Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Am J Respir Crit Care Med 1996 1.44
25 Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol 1983 1.43
26 Surface characteristics of the U-937 human histiocytic lymphoma cell line: specific changes during inducible morphologic and functional differentiation in vitro. Haematol Blood Transfus 1981 1.42
27 IL-5 priming of the PMA-induced oxidative metabolism of human eosinophils from allergic and normal subjects during a pollen season. Clin Exp Allergy 2001 1.41
28 Activation of B-lymphocytes during pollen season. Effect of immunotherapy. Clin Exp Allergy 1998 1.40
29 The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. J Allergy Clin Immunol 1982 1.40
30 Eosinophil granule proteins in cardiopulmonary bypass with and without heparin coating. Ann Thorac Surg 1995 1.40
31 Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis 1993 1.39
32 Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol 1997 1.37
33 Human eosinophil peroxidase: purification and characterization. J Immunol 1985 1.36
34 Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents. Am J Med 1989 1.33
35 Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol 1989 1.32
36 Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis 1990 1.31
37 Enhancement of factor XII dependent reactions by eosinophil cationic protein. Thromb Res 1979 1.30
38 Cationic proteins of human granulocytes. IV. Esterase activity. Lab Invest 1975 1.28
39 Serum myeloperoxidase and lactoferrin in neutropenia. Scand J Haematol 1977 1.25
40 Kinetic studies of phagocytosis. I. The serum independent particle uptake by PMN from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1978 1.24
41 Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand J Clin Lab Invest 1994 1.23
42 Kinetic studies of phagocytosis of IgG-coated latex particles with a thrombocyte counter. J Lab Clin Med 1977 1.22
43 The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis 1989 1.21
44 Variations of blood eosinophils and eosinophil cationic protein in serum in patients with bronchial asthma. Studies during inhalation challenge test. Allergy 1978 1.19
45 Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. Respir Med 2001 1.18
46 Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol 1991 1.17
47 Neutrophils from term and preterm newborn infants express the high affinity Fcgamma-receptor I (CD64) during bacterial infections. Pediatr Res 1999 1.16
48 The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol 1988 1.15
49 Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy 1991 1.15
50 Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity. J Immunol 1975 1.15
51 Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol 1990 1.14
52 IL-5 and TNF-alpha participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis. Dig Dis Sci 2001 1.12
53 Neutrophil and eosinophil granulocytes in bacterial infection: sequential studies of cellular and serum levels of granule proteins. Br J Haematol 1978 1.11
54 Studies on the phagocytic activity of the granulocytes in psoriasis and palmoplantar pustulosis. Br J Dermatol 1983 1.11
55 Nasal and ocular symptoms, tear film stability and biomarkers in nasal lavage, in relation to building-dampness and building design in hospitals. Int Arch Occup Environ Health 1999 1.10
56 Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol 1996 1.09
57 Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation 1990 1.09
58 Effects of serum and cations on the selective release of granular proteins from human netrophils during phagocytosis. Scand J Haematol 1979 1.08
59 Cationic proteins of human granulocytes. I. Isolation of the cationic proteins from the granules of leukaemic myeloid cells. Scand J Haematol 1972 1.07
60 Effect of hyaluronic acid on phagocytosis of opsonized latex particles. Scand J Immunol 1980 1.07
61 The role of the human neutrophil in the inflammatory reaction. Allergy 1980 1.06
62 Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome. Gut 2004 1.06
63 Piecemeal degranulation of peripheral blood eosinophils: a study of allergic subjects during and out of the pollen season. Am J Respir Cell Mol Biol 2000 1.05
64 The development of an assay for human neutrophil lipocalin (HNL)--to be used as a specific marker of neutrophil activity in vivo and vitro. J Immunol Methods 1994 1.05
65 FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease. Heart 2005 1.04
66 Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am J Gastroenterol 1999 1.04
67 Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J Allergy Clin Immunol 1991 1.03
68 Kinetic studies of cell migration in a modified Boyden chamber: dependence on cell concentration and effects of the chymotrypsin-like cationic protein of human granulocytes. J Immunol 1979 1.03
69 Human eosinophil cationic proteins (ECP and EPX) and their suppressive effects on lymphocyte proliferation. Immunobiology 1986 1.03
70 The effect of eosinophils on collagen gel contraction and implications for tissue remodelling. Clin Exp Immunol 2004 1.03
71 Analysis of fluid-phase mediators. Eur Respir J Suppl 2002 1.02
72 Serum levels of granulocyte-colony stimulating factor (G-CSF) in bacterial and viral infections, and in atypical pneumonia. Br J Haematol 1994 1.01
73 Eosinophil cationic protein in inflammatory synovial effusions as evidence of eosinophil involvement. Ann Rheum Dis 1984 1.01
74 Biopsy markers of airway inflammation and remodelling. Respir Med 2000 1.00
75 Kinetic studies of neutrophil phagocytosis. V. studies on the co-operation between the Fc and C3b receptors. Immunology 1982 0.99
76 Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjögren's syndrome. BHR Study Group. Bronchial hyperresponsiveness. Allergy 2000 0.99
77 Active participation of eosinophils in patch test reactions to inhalant allergens in patients with atopic dermatitis. Br J Dermatol 1988 0.98
78 The FRISC experience with troponin T. Use as decision tool and comparison with other prognostic markers. Eur Heart J 1998 0.98
79 Expression of laminins in the airways in various types of asthmatic patients: a morphometric study. Am J Respir Cell Mol Biol 1996 0.98
80 Eosinophil activation in allergic disease. Int Arch Allergy Appl Immunol 1987 0.98
81 Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1994 0.97
82 The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma. Allergy 2005 0.97
83 Changes in the ocular and nasal signs and symptoms of aircrews in relation to the ban on smoking on intercontinental flights. Scand J Work Environ Health 2000 0.96
84 Perifolliculitis capitis abscedens et suffodiens (Hoffman). Complete healing associated with oral zinc therapy. Arch Dermatol 1985 0.96
85 Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease. Br J Haematol 2001 0.96
86 Serum ferritin during infection. A longitudinal study. Scand J Haematol 1978 0.95
87 Eosinophil cationic protein (ECP) in saliva: a new marker of disease activity in bronchial asthma. Respir Med 2001 0.95
88 Respiratory symptoms, bronchial responsiveness, and cellular characteristics of induced sputum in elite swimmers. Allergy 1998 0.95
89 Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: correlation to effects on cellular variables. Eur Respir J 1988 0.94
90 The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post-translational modifications. Clin Exp Allergy 2007 0.94
91 Bronchial biopsy findings in intermittent or "early" asthma. J Allergy Clin Immunol 1996 0.94
92 Ultrastructure of bronchial biopsies from patients with allergic and non-allergic asthma. Respir Med 2005 0.94
93 Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study. Thorax 2003 0.94
94 Inflammation and structural changes in the airways of patients with primary Sjögren's syndrome. Respir Med 2001 0.94
95 The combined action of hyaluronic acid and fibronectin stimulates neutrophil migration. J Immunol 1985 0.93
96 Radioimmunoassay of serum myoglobin in neuromuscular diseases. J Neurol Neurosurg Psychiatry 1981 0.93
97 Purification and characterization of a new cationic protein--eosinophil protein-X (EPX)--from granules of human eosinophils. Immunology 1983 0.92
98 Nasal patency and biomarkers in nasal lavage--the significance of air exchange rate and type of ventilation in schools. Int Arch Occup Environ Health 1998 0.92
99 Polymorphism of the eosinophil cationic protein-gene is related to the expression of allergic symptoms. Clin Exp Allergy 2002 0.92
100 Eosinophil cationic protein alters proteoglycan metabolism in human lung fibroblast cultures. Eur J Cell Biol 1992 0.91
101 Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery. Scand Cardiovasc J 2000 0.91
102 Lactoferrin, lysozyme, and beta 2-microglobulin levels in cerebrospinal fluid: differential indices of CNS inflammation. Inflammation 1982 0.91
103 Human neutrophil lipocalin, a highly specific marker for acute exacerbation in cystic fibrosis. Eur Respir J 1999 0.91
104 Challenge with gliadin induces eosinophil and mast cell activation in the jejunum of patients with celiac disease. Am J Med 1989 0.91
105 Human neutrophil lipocalin (HNL) is a specific granule constituent of the neutrophil granulocyte. Studies in bronchial and lung parenchymal tissue and peripheral blood cells. Histochem Cell Biol 1997 0.91
106 Serum lysozyme: a potential marker of monocyte/macrophage activity in rheumatoid arthritis. Rheumatology (Oxford) 1999 0.91
107 Cardiac troponin I is associated with severity of myxomatous mitral valve disease, age, and C-reactive protein in dogs. J Vet Intern Med 2010 0.90
108 New method for the measurement of eosinophil migration. J Leukoc Biol 1987 0.90
109 Glutathione in bronchoalveolar lavage fluid from smokers is related to humoral markers of inflammatory cell activity. Inflammation 1989 0.90
110 Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1997 0.90
111 Kinetics of the agglutination of IgG-coated latex particles by C1q: the influence of heat-labile serum components. Scand J Immunol 1979 0.89
112 The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation. Allergy 1993 0.89
113 Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. J Immunol Methods 1991 0.89
114 Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season. J Allergy Clin Immunol 1992 0.89
115 CD64 (Fcgamma receptor I) cell surface expression on maturing neutrophils from preterm and term newborn infants. Acta Paediatr 2005 0.89
116 Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. Ann Thorac Surg 1996 0.89
117 Effects of in vivo administration of G-CSF on neutrophil and eosinophil adhesion. Br J Haematol 1997 0.88
118 Low levels of eosinophil cationic proteins in patients with asthma. Lancet 1977 0.88
119 Schistosoma mansoni: further studies of the interaction between schistosomula and granulocyte-derived cationic proteins in vitro. Parasitology 1984 0.88
120 New reference values for routine blood samples and human neutrophilic lipocalin during third-trimester pregnancy. Scand J Clin Lab Invest 2001 0.87
121 Platelet adhesion in patients prone to arterial and venous thrombosis: the impact of gender, smoking and heredity. Scand J Clin Lab Invest 1998 0.87
122 Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season. Clin Exp Allergy 1991 0.86
123 Angiostrongylus cantonensis: role of eosinophils in the neurotoxic syndrome (Gordon-like phenomenon). Exp Parasitol 1989 0.86
124 Ultrastructural characterization of platelet-activating factor-stimulated human eosinophils from patients with asthma. Clin Sci (Lond) 1993 0.86
125 Raised circulating levels of the eosinophil cationic protein in ankylosing spondylitis: relation with the inflammatory activity and the influence of sulphasalazine treatment. Ann Rheum Dis 1987 0.86
126 Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn. Gut 2005 0.86
127 Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J Thorac Cardiovasc Surg 1995 0.86
128 Serum-levels of lactoferrin, lysozyme and myeloperoxidase in normal, infection-prone and leukemic children. Clin Chim Acta 1984 0.86
129 Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991 0.86
130 Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. J Thorac Cardiovasc Surg 1992 0.86
131 Purification and characterization of eosinophil cationic protein from normal human eosinophils. Eur J Haematol 1988 0.85
132 Eosinophil involvement in rheumatoid arthritis as reflected by elevated serum levels of eosinophil cationic protein. Clin Exp Immunol 1985 0.85
133 In vitro studies of the interaction between heparin and eosinophil cationic protein. Allergy 1991 0.85
134 Granulocyte colony-stimulating factor (G-CSF) induces the production of cytokines in vivo. Br J Haematol 2000 0.85
135 Myeloperoxidase and lactoferrin of blood neutrophils and plasma in chronic granulocytic leukaemia. Scand J Haematol 1977 0.85
136 Nasal challenge shows pathogenetic relevance of specific IgE serum antibodies for nasal symptoms caused by hexahydrophthalic anhydride. Clin Exp Allergy 1994 0.85
137 Urinary neutrophil gelatinase-associated lipocalin to hepcidin ratio as a biomarker of acute kidney injury in intensive care unit patients. Minerva Anestesiol 2014 0.85
138 Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis. Allergy 1987 0.85
139 The influence of serum on random migration and chemotaxis of polymorphonuclear leucocytes: methodological evaluation using sera from infection-prone patients and normals. Scand J Immunol 1980 0.85
140 Blood eosinophils and eosinophil cationic protein after acute myocardial infarction or corticosteroid administration. Br J Haematol 1979 0.85
141 A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. J Allergy Clin Immunol 2001 0.84
142 Radioimmunoassays of human myoglobin in serum and urine. Scand J Clin Lab Invest 1979 0.84
143 The effect of granulocyte colony-stimulating factor (G-CSF) on the degranulation of secondary granule proteins from human neutrophils in vivo may be indirect. Br J Haematol 1996 0.84
144 Activation of blood coagulation during inhalation challenge tests. Allergy 1981 0.84
145 Effects of salmeterol on mucosal inflammation in asthma: a placebo-controlled study. Eur Respir J 2002 0.84
146 Increased in vivo secretory activity of neutrophil granulocytes in patients with psoriasis and palmoplantar pustulosis. Arch Dermatol Res 1985 0.84
147 The peroxidase activity and cellular content of granule proteins in PMN during pregnancy. Br J Haematol 1983 0.84
148 Effects of in vivo administration of G-CSF on neutrophil functions in healthy volunteers. Eur J Haematol 1997 0.84
149 Human neutrophil lipocalin (HNL) and myeloperoxidase (MPO). Studies of lung lavage fluid and lung tissue. Respir Med 2000 0.84
150 Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' duration. J Allergy Clin Immunol 2001 0.84
151 Nasal lavage biomarkers: effects of water damage and microbial growth in an office building. Arch Environ Health 2001 0.84
152 Eosinophil activation in the lung is related to lung damage in adult respiratory distress syndrome. Am Rev Respir Dis 1987 0.84
153 Migratory responses of eosinophil and neutrophil granulocytes from patients with asthma. J Allergy Clin Immunol 1990 0.83
154 Priming of eosinophil and neutrophil migratory responses by interleukin 3 and interleukin 5. APMIS 1994 0.83
155 Inflammatory system activation during cardiopulmonary bypass as an indicator of biocompatibility: a randomized comparison of bubble and membrane oxygenators. Scand J Thorac Cardiovasc Surg 1990 0.83
156 A method to study apoptosis in eosinophils by flow cytometry. J Immunol Methods 2000 0.83
157 The role of the eosinophil granulocyte in the inflammatory reaction. Allergy 1979 0.83
158 Eosinophilic cationic protein (ECP) in skin disorders. Acta Derm Venereol 1991 0.83
159 Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemicals Markers of Acute Coronary Syndromes. Coron Artery Dis 1995 0.83
160 Changes of symptoms, tear film stability and eosinophilic cationic protein in nasal lavage fluid after re-exposure to a damp office building with a history of flooding. Indoor Air 2007 0.83
161 Signs of neutrophil and eosinophil activation in adult respiratory distress syndrome. Crit Care Med 1984 0.83
162 Regulation of human eosinophil migration across lung epithelial monolayers by distinct calcium signaling mechanisms in the two cell types. J Immunol 1999 0.83
163 Nasal patency and lavage biomarkers in relation to settled dust and cleaning routines in schools. Scand J Work Environ Health 1999 0.83
164 C5a, interleukin-8 and tumour necrosis factor-alpha-induced changes in granulocyte and monocyte expression of complement receptors in whole blood and on isolated leukocytes. Scand J Immunol 2006 0.83
165 Cationic proteins of human granulocytes. V. Interaction with plasma protease inhibitors. Scand J Clin Lab Invest 1975 0.82
166 Cell specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage fluid of patients with respiratory conditions and healthy subjects. Thorax 2002 0.82
167 Bronchial mucosal mast cells in asymptomatic smokers relation to structure, lung function and emphysema. Respir Med 2005 0.82
168 The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X. Allergy 1993 0.82
169 Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population. Allergy 1994 0.82
170 Kinetic studies of phagocytosis. IV. Cellular defects and humoral inhibition as causes of impaired neutrophil phagocytosis in sarcoidosis. Clin Exp Immunol 1982 0.82
171 Human neutrophil lipocalin: normal levels and use as a marker for invasive infection in the newborn. Acta Paediatr 2004 0.82
172 Interaction and complex-formation between the eosinophil cationic protein and alpha 2-macroglobulin. Biochem J 1987 0.82
173 Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study. Eur J Cardiothorac Surg 1997 0.82
174 Peripheral blood markers: evaluation of inflammation in asthma. Eur Respir J Suppl 1998 0.82
175 An immunofluorescent method for a specific demonstration of granulocytes and some of their proteins (ECP and CCP). Histochemistry 1986 0.82
176 Red blood cell preservation in protein-poor media. I. Leukocyte enzymes as a cause of hemolysis. Transfusion 1978 0.82
177 Dexamethasone treatment of infants at risk for chronic lung disease: surfactant components and inflammatory parameters in airway specimens. Pediatr Res 1994 0.82
178 Inhibition of neutrophil and eosinophil chemotactic responses to PAF by the PAF-antagonists WEB-2086, L-652,731, and SRI-63441. J Leukoc Biol 1990 0.82
179 Serum eosinophil cationic protein in asthma of farmers. Scand J Clin Lab Invest 2000 0.81
180 Allergen-induced changes in nasal secretory responsiveness and eosinophil granulocytes. Acta Otolaryngol 1991 0.81
181 (99m)Tc-HMPAO (Ceretec) is stored in and released from the granules of eosinophil granulocytes. Br J Haematol 2001 0.81
182 Myoglobin turnover--influence of renal and extrarenal factors. J Lab Clin Med 1978 0.81
183 Defects in polymorphonuclear neutrophil function and susceptibility to infection in children. Scand J Clin Lab Invest 1986 0.81
184 Eosinophil chemotactic activity in allergic patients during the birch pollen season: the effect of immunotherapy. Int Arch Allergy Appl Immunol 1987 0.81
185 The formation of eosinophil and neutrophil chemotactic activity during a pollen season and after allergen challenge. J Allergy Clin Immunol 1989 0.81
186 The molecular basis of the hyaluronic acid-mediated stimulation of granulocyte function. J Immunol 1987 0.81
187 Blood eosinophil leucocyte and eosinophil cationic protein. In vivo study of the influence of beta-2-adrenergic drugs and steroid medication. Scand J Respir Dis 1978 0.81
188 Muscle cell leakage of myoglobin after long-term exercise and relation to the individual performances. Int J Sports Med 1986 0.81
189 Increased in vivo activation of neutrophils and complement in sickle cell disease. Am J Trop Med Hyg 1993 0.81
190 Neutrophil function in infection-prone children. Arch Dis Child 1980 0.81
191 Eosinophil cationic protein (ECP) in the cerebrospinal fluid. J Neurol Sci 1983 0.81
192 Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy. J Allergy Clin Immunol 1997 0.81
193 The value of serum myoglobin determinations in the early diagnosis of acute myocardial infarction. Acta Med Scand 1984 0.81
194 Blood eosinophil numbers and activity during 24 hours: effects of treatment with budesonide and bambuterol. J Allergy Clin Immunol 1992 0.81
195 Serum-mediated stimulation and inhibition of neutrophil locomotion in sarcoidosis. Eur J Respir Dis 1984 0.81
196 Enhancement of urokinase-induced plasminogen activation by the cationic protein of human eosinophil granulocytes. Thromb Res 1979 0.81
197 Human alveolar macrophages from smokers have an impaired capacity to secrete LTB4 but not other chemotactic factors. Eur J Respir Dis 1987 0.81
198 The chemotactic activity of normal and complement-activated serum as measured by the leading-front method using a Boyden chamber. Scand J Immunol 1984 0.81
199 Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. J Allergy Clin Immunol 1990 0.81
200 Monitoring of asthma inflammation by serum measurements of eosinophil cationic protein (ECP). A new clinical approach to asthma management. Respir Med 1995 0.80
201 Acoustic rhinometry and lavage biomarkers in relation to some building characteristics in Swedish schools. Indoor Air 2001 0.80
202 The differential release of eosinophil granule proteins. Studies on patients with acute bacterial and viral infections. Clin Exp Allergy 1995 0.80
203 The chemokinetic inhibitory factor (CIF) in serum of CLL patients: correlation with infection propensity and disease activity. Scand J Haematol 1985 0.80
204 Patients with renal cancer have a larger proportion of high-density blood monocytes with increased lucigenin-enhanced chemiluminescence. Inflammation 1994 0.80
205 The distribution of myeloperoxidase, eosinophil cationic protein, albumin and urea in sequential bronchoalveolar lavage. Eur Respir J 1991 0.80
206 Periodontitis in the primary dentition associated with Actinobacillus actinomycetemcomitans infection and leukocyte dysfunction. A 3 1/2 year follow-up. J Clin Periodontol 1990 0.80
207 Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II). J Am Coll Cardiol 1999 0.80
208 Changes in non-specific nasal reactivity and eosinophil influx and activation after allergen challenge. Clin Exp Allergy 1990 0.80
209 Role of eosinophilic granulocytes in women with infertility and pelvic adhesions. Inflammation 1994 0.80
210 A fast and sensitive radioimmunoassay of human myoglobin for use in the early diagnosis of heart infarction. Clin Chim Acta 1980 0.80
211 Lucigenin-enhanced chemiluminescence in blood is increased in cancer. Am J Clin Pathol 1989 0.80
212 Administration of G-CSF to healthy subjects: the effects on eosinophil counts and mobilization of eosinophil granule proteins. Br J Haematol 1997 0.80
213 The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991 0.80
214 Lactoferrin, lysozyme, and beta 2-microglobulin in cerebrospinal fluid. Elevated levels in patients with acute cerebrovascular lesions as indices of inflammation. Stroke 1981 0.80
215 Gastrointestinal sensitivity to soy and milk proteins in patients with IgA nephropathy. Clin Nephrol 2010 0.80
216 Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. Artif Organs 1991 0.79
217 Activation of inflammatory systems during cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg 1988 0.79
218 Eosinophils and neutrophils in biopsies from the middle ear of atopic children with otitis media with effusion. Inflamm Res 1999 0.79
219 Coagulation and fibrinolysis during the normal menstrual cycle. Ups J Med Sci 1989 0.79
220 Phagocyte activation in preterm infants following premature rupture of the membranes or chorioamnionitis. Acta Paediatr 2000 0.79
221 Mucosal reactivity to cow's milk protein in coeliac disease. Clin Exp Immunol 2007 0.79
222 Transfer of 99mTc DTPA and bronchoalveolar lavage findings in patients with asymptomatic extrinsic allergic alveolitis. Thorax 1990 0.79
223 Releasability of human hypereosinophilic eosinophils is related to the density of the cells. Br J Haematol 1994 0.79
224 Lactoferrin, myeloperoxidase, lysozyme and eosinophil cationic protein in exudate in delayed type hypersensitivity. Allergy 1988 0.79
225 Eosinophil cationic protein stimulates migration of human lung fibroblasts in vitro. Scand J Immunol 2009 0.79
226 Partial characterization and identification of chemokinetic factors in serum. Scand J Immunol 1983 0.79
227 Metal content of neutrophil granules is altered in chronic inflammation. Inflammation 1989 0.79
228 Kinetic retrieval of eosinophil cationic protein, hyaluronan, secretory IgA, albumin, and urea during BAL in healthy subjects. Chest 1995 0.79
229 Specific binding of B-CLL cell-derived chemokinetic inhibitory factor (CIF) to human polymorphonuclear leukocytes. Eur J Haematol 1987 0.79
230 Indoor air pollutants in schools: nasal patency and biomarkers in nasal lavage. Allergy 2000 0.79
231 Kinetic studies of phagocytosis. II. The serum-independent uptake of IgG-coated particles by polymorphonuclear leukocytes from uremic patients on regular dialysis treatment. J Lab Clin Med 1979 0.79
232 Hyaluronic acid stimulates neutrophil function in vitro and in vivo. A review of experimental results and a presentation of a preliminary clinical trial. Scand J Infect Dis Suppl 1980 0.79
233 Effects of heparin-coating of cardiopulmonary bypass circuits on leukocytes during simulated extracorporeal circulation. Cardiovasc Surg 1997 0.79
234 Eosinophil cationic protein is stored in, but not produced by, peripheral blood neutrophils. Clin Exp Allergy 2002 0.79
235 Myoglobinemia after myocardial infarction; influence of renal function. Eur J Cardiol 1978 0.79
236 Neutrophil and eosinophil degranulation during hemodialysis are mediated by the dialysis membrane. Nephron 1982 0.78
237 Differential expression of the C5a receptor and complement receptors 1 and 3 after LPS stimulation of neutrophils and monocytes. Scand J Immunol 2004 0.78
238 Role of the eosinophil in bronchial asthma. Eur J Respir Dis Suppl 1982 0.78
239 Serum eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis. Clin Exp Allergy 1998 0.78
240 Closure of patent ductus arteriosus decreases pulmonary myeloperoxidase in premature infants with respiratory distress syndrome. Biol Neonate 1995 0.78
241 Chemotactic activity of LTB4 in man. Allergy 1986 0.78
242 Cow's milk protein sensitivity assessed by the mucosal patch technique is related to irritable bowel syndrome in patients with primary Sjögren's syndrome. Clin Exp Allergy 2008 0.78
243 Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics. Eur Respir J 1997 0.78
244 Diagnosis, size estimation and prediction of acute myocardial infarction from S-myoglobin observations. A system analysis to assess the influence of various sources of variability. Scand J Clin Lab Invest Suppl 1980 0.78
245 Hemodialysis-induced increase in serum lactoferrin and serum eosinophil cationic protein as signs of local neutrophil and eosinophil degranulation. Nephron 1981 0.78
246 Sequential studies on serum-levels of lysozyme, lactoferrin and eosinophil cationic protein in alcoholics after alcohol withdrawal. Scand J Haematol 1980 0.78
247 Influence of personal factors on nasal patency and lavage biomarkers in white-collar workers. Rhinology 2000 0.78
248 Polymorphonuclear neutrophil function and infections following splenectomy in childhood. Scand J Haematol 1986 0.78
249 Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro. Perfusion 1997 0.78
250 Myocardial and skeletal muscle function in habitual alcoholics and its relation to serum myoglobin. Am J Cardiol 1986 0.78
251 Chemiluminescence of polymorphonuclear leukocytes and whole blood during acute bacterial infection. Scand J Infect Dis 1989 0.78
252 The eosinophil granulocyte in psoriasis. Br J Dermatol 1990 0.78
253 Monocytes, but not macrophages, produce the eosinophil cationic protein. APMIS 2001 0.78
254 Interleukin-2 inhibits eosinophil migration but is counteracted by IL-5 priming. Clin Exp Allergy 2001 0.78
255 Elevated circulating levels of eosinophil cationic protein in uremia as signs of abnormal eosinophil homeostasis. Nephron 1984 0.78
256 Myeloperoxidase in human lung lavage. II. Internalization of myeloperoxidase by alveolar macrophages. Inflammation 1990 0.78
257 Markers for eosinophils and T-lymphocytes as predictors of late asthmatic response. Allergy 1993 0.78
258 Hyaluronan and myeloperoxidase in human peritoneal fluid during genital inflammation. Inflammation 1994 0.78
259 Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction. Heart 2005 0.77
260 Evidence of eosinophil, neutrophil, and mast-cell mediators in the effusion of OME patients with and without atopy. Allergy 2000 0.77
261 Eosinophils and cellular injury: the Gordon phenomenon as a model. N Engl Reg Allergy Proc 1985 0.77
262 Identification of a serum-derived promotor of granulocyte granule secretion: study on a patient with chronic pruritus. Immunology 1982 0.77
263 Neutrophil phagocytosis in sarcoidosis. Reduced C3b receptor-mediated phagocytosis in active and silent sarcoidosis. Clin Exp Immunol 1985 0.77
264 Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocyte and complement activation. Perfusion 1994 0.77
265 Effects of UVB treatment on neutrophil function in psoriatic patients and healthy subjects. Acta Derm Venereol 1990 0.77
266 The chemotactic response of granulocytes to the low molecular weight chemoattractants f-MLP, C5f, and LTB4 is dependent on chemokinetic factors. J Leukoc Biol 1985 0.77
267 Muscle ATP and lactate and the release of myoglobin and carbanhydrase III in acute lower-limb ischaemia. Eur J Vasc Surg 1991 0.77
268 Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera. Immunology 1982 0.77
269 Oxygen radical production by blood eosinophils is reduced during birch pollen season in allergic patients. Clin Exp Allergy 1996 0.77
270 Measurements of ECP in serum and the impact of plasma coagulation. Allergy 2000 0.77
271 Self-reported food intolerance and mucosal reactivity after rectal food protein challenge in patients with rheumatoid arthritis. Scand J Rheumatol 2010 0.77
272 Possible reasons for the prognostic value of troponin-T on admission in patients with ST-elevation myocardial infarction. Coron Artery Dis 2001 0.77
273 Elastase in the different primary granules of the human neutrophil. Biochem Biophys Res Commun 1985 0.77
274 The content of eosinophil cationic protein in eosinophil leucocytes. Study on normal controls and patients with bronchial asthma. Allergy 1978 0.77
275 Identification of a chemokinetic inhibitor in serum from patients with chronic lymphocytic leukaemia. Scand J Haematol 1982 0.77
276 Increased nitric oxide in expired air in patients with Sjögren's syndrome. BHR study group. Bronchial hyperresponsiveness. Eur Respir J 1999 0.77
277 Serum myoglobin in thyroid disease. Acta Endocrinol (Copenh) 1980 0.77
278 Monocyte activation in patients with non-seminomatous germ cell tumour of the testis before and after tumour eradication. J Clin Pathol 1996 0.77
279 Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effects of topical glucocorticosteroid treatment. Allergy 1989 0.77
280 Human eosinophil-derived neurotoxin and eosinophil protein X are likely the same protein. J Immunol 1989 0.77
281 Effects of rhinovirus-induced common colds on granulocyte activity in allergic rhinitis. J Infect 2002 0.77
282 Neutrophil leucocyte activation in severe malaria. Trans R Soc Trop Med Hyg 1996 0.76
283 Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonide. J Allergy Clin Immunol 1990 0.76
284 Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit. Perfusion 1996 0.76
285 Inflammation markers in nasal lavage, and nasal symptoms in relation to relocation to a newly painted building: a longitudinal study. Int Arch Occup Environ Health 1999 0.76
286 Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems. Ann Thorac Surg 1995 0.76
287 Increased chemokinetic and chemotactic responses of eosinophils in asthmatic patients. Allergy 1991 0.76
288 Total absence of eosinophils in a patient with chronic urticaria and vitiligo. Eur J Haematol 1988 0.76
289 A fasting and vegetarian diet treatment trial on chronic inflammatory disorders. Acta Derm Venereol 1983 0.76
290 Regional generation of free oxygen radicals during cardiopulmonary bypass in children. J Thorac Cardiovasc Surg 1995 0.76
291 Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery. Artif Organs 1996 0.76
292 Hyaluronan and myeloperoxidase in human peritoneal fluid during genital inflammation. Inflammation 1994 0.76
293 The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease. Leuk Lymphoma 2001 0.76
294 Bronchial reactivity in asthmatic children at high and low altitude. Effect of budesonide. Am J Respir Crit Care Med 1995 0.76
295 Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg 1994 0.76
296 No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits. Ann Thorac Surg 2000 0.75
297 Serum eosinophilic cationic protein and lactoferrin related to smoking history and lung function. Eur Respir J 1994 0.75
298 Circulating cytokines and granulocyte-derived enzymes during complex heart surgery. A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits. Scand J Thorac Cardiovasc Surg 1995 0.75
299 Ankylosing spondylitis: a chronic inflammatory disease with iron overload in granulocytes and platelets. Ann Rheum Dis 1986 0.75
300 Inverse relationship between interferon production by mononuclear leucocytes and oxidative metabolism of neutrophil granulocytes in infection prone children. Clin Exp Immunol 1985 0.75
301 Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis. Arch Dermatol Res 1987 0.75
302 Evidence of mast cell activity in the middle ears of children with otitis media with effusion. Laryngoscope 1999 0.75
303 Mast cells and tryptase in the middle ear of children with otitis media with effusion. Int J Pediatr Otorhinolaryngol 1999 0.75
304 Effect of long-term treatment with inhaled budesonide or theophylline on lung function, airway reactivity and asthma symptoms. Respir Med 2002 0.75
305 Neutrophil function in patients with primary Sjögren's syndrome: relation to infection propensity. Ann Rheum Dis 1991 0.75
306 Neutrophil and eosinophil involvement of the small bowel affected by chronic alcoholism. Gut 1988 0.75
307 Biomaterial-dependent blood activation during simulated extracorporeal circulation: a study of heparin-coated and uncoated circuits. Thorac Cardiovasc Surg 1997 0.75
308 The stimulus-dependent release of eosinophil cationic protein and eosinophil protein x increases in apoptotic eosinophils. Scand J Immunol 2003 0.75
309 Inflammatory markers of outcome. Eur Respir J Suppl 1996 0.75
310 Cationic proteins of human granulocytes: Enhancement of phagocytosis ofStaphylococcus protein A-IgG complexes. Inflammation 1976 0.75
311 Myeloid regeneration after bone-marrow transplantation monitored by serum measurements of myeloperoxidase, lysozyme and lactoferrin. Eur J Haematol 1987 0.75
312 The chemokinetic inhibitory factor derived from chronic lymphocytic leukaemia cells. Partial purification and characterization of a new lymphokine. Scand J Immunol 1986 0.75
313 Bubble and membrane oxygenators--comparison of postoperative organ dysfunction with special reference to inflammatory activity. Scand J Thorac Cardiovasc Surg 1990 0.75
314 [Specialist examination in clinical chemistry. Voluntary examination for higher competence]. Lakartidningen 1993 0.75
315 Evaluation of urinary myoglobin assay test for myocardial infarction. Scand J Clin Lab Invest 1978 0.75
316 Granulocyte proteases in human maxillary sinus secretions. Scand J Infect Dis 1983 0.75
317 The effect of rGM-CSF on neutrophil and eosinophil regeneration after ABMT as monitored by circulating levels of granule proteins. Br J Haematol 1994 0.75
318 C3b receptor-mediated phagocytosis in sarcoidosis with extra-thoracic manifestations. Eur J Respir Dis 1985 0.75
319 Indices of inflammatory cell activity and pulmonary function in different stages of sarcoidosis. Acta Med Scand 1982 0.75
320 Beta 2-microglobulin, lysozyme and lactoferrin in cerebrospinal fluid in patients with lymphoma or leukaemia: relationship to CNS involvement and the effect of prophylactic intrathecal treatment with methotrexate. Br J Haematol 1987 0.75
321 [How to manage quality assurance at laboratories? A specialist's examination is necessary in the specialty of clinical chemistry]. Lakartidningen 1995 0.75
322 Cellular origin of the chemokinetic inhibitor of polymorphononuclear leucocytes found in sera from patients with chronic lymphocytic leukaemia. Scand J Haematol 1983 0.75
323 Measurement of specific markers in the monitoring of the bronchial inflammation in asthma. Ann N Y Acad Sci 1991 0.75
324 Influence of two blood conservation techniques (cardiotomy reservoir versus cell-saver) on biocompatibility of the heparin coated cardiopulmonary bypass circuit during coronary revascularization surgery. J Card Surg 1998 0.75
325 Chemotactic properties of retained maxillary sinus secretions. Acta Otolaryngol 1984 0.75
326 Serum ferritin during infection. A longitudinal study in renal transplant patients. Acta Med Scand 1979 0.75
327 Bone-marrow regeneration after therapy-induced hypoplasia monitored by serum measurements of lactoferrin, lysozyme and myeloperoxidase. Scand J Haematol 1986 0.75
328 Inflammatory response during simulated extracorporeal circulation with addition of nitric oxide. J Cardiovasc Surg (Torino) 2000 0.75
329 Neutrophil and eosinophil degranulation by hemodialysis membranes. Contrib Nephrol 1984 0.75
330 Ethanol reduces myoglobin release during isokinetic muscle exercise. Acta Med Scand 1986 0.75
331 Beta-thromboglobulin in inflammatory synovial fluid. Inflammation 1983 0.75
332 The diagnostic and prognostic value of serum-myoglobin determinations in acute myocardial infarction. Ups J Med Sci 1983 0.75
333 [The mystery of eosinophil granulocytes--a 100 year jubilee]. Lakartidningen 1979 0.75
334 Bactericidal proteins and neutral proteases in diabetes neutrophils. Diabetologia 1986 0.75
335 Blood eosinophils from asymptomatic allergics have a reduced capacity to produce oxygen-free radicals. Allergy 1998 0.75
336 Levels of eosinophil cationic protein and myeloperoxidase from chronic middle ear effusion in patients with allergy and/or acute infection. Otolaryngol Head Neck Surg 1996 0.75
337 Noninvasive risk stratification in unstable coronary artery disease: exercise test and biochemical markers. FRISC Study Group. Am J Cardiol 1997 0.75
338 Blood eosinophil leucocytes and eosinophil cationic protein. Diurnal variation in normal subjects and patients with bronchial asthma. Scand J Respir Dis 1978 0.75
339 Generation of heat-labile chemotactic activity in blood after inhalation challenge and its relationship to neutrophil and monocyte/macrophage turnover and activity. Allergy 1982 0.75
340 Serum levels of neutrophil and eosinophil chemotactic activities in mastocytosis. Agents Actions 1989 0.75
341 Patient reactions and granulocyte degranulation during hemodialysis with cuprophane and polycarbonate membranes. A double-blind study. Blood Purif 1986 0.75
342 [Does examination play any role in continuing education? Experiences from clinical chemistry]. Lakartidningen 1993 0.75
343 Immunoglobulin and inflammatory markers profiles in mycetoma. East Afr Med J 1996 0.75
344 Inflammatory markers in acute exacerbations of obstructive pulmonary disease: predictive value in relation to smoking history. Respir Med 1999 0.75
345 Acoustic rhinometry in epidemiological studies--nasal reactions in Swedish schools. Rhinol Suppl 2000 0.75
346 Eosinophil peroxidase: a new serum marker of atopy and bronchial hyper-responsiveness. Respir Med 1996 0.75
347 Serum and urinary myoglobin in alcoholics. Acta Med Scand 1980 0.75
348 Enhanced adhesion to laminin by apoptotic eosinophils. Scand J Immunol 2003 0.75
349 Diagnostic and prognostic significance of serum measurements of lactoferrin, lysozyme and myeloperoxidase in acute myeloid leukemia (AML): recognition of a new variant, high-lactoferrin AML. Eur J Haematol 1987 0.75
350 Defective C3b receptor-mediated phagocytosis of neutrophils in patients with primary biliary cirrhosis. Scand J Gastroenterol 1987 0.75
351 Elevated serum levels of lactoferrin and eosinophil cationic protein in schizophrenic patients. Br J Psychiatry 1982 0.75
352 Effects of drainage in the treatment of acute maxillary sinusitis. Acta Otolaryngol 1983 0.75
353 The presence of eosinophil cationic protein in middle ear effusion. Otolaryngol Head Neck Surg 1993 0.75
354 Eeosinophils in allergic contact dermatitis. Acta Derm Venereol 1992 0.75
355 The mechanisms of serum-treated zymosan (STZ)-induced oxidative metabolism by human eosinophils and the effects of IL-5 priming. Allergy 2001 0.75
356 Changes in inflammatory markers following treatment of acute exacerbations of obstructive pulmonary disease. Respir Med 2001 0.75
357 [Degranulation of human eosinophilic granulocytes by the platelet activating factor]. Pneumologie 1990 0.75
358 Variations in serum myoglobin after a 2-min isokinetic exercise test and the effects of training. Eur J Appl Physiol Occup Physiol 1984 0.75
359 Eosinophils and respiratory disease. Respir Med 2001 0.75
360 Production of chemokinetic inhibitory factor (CIF) by normal blood and spleen B lymphocytes. Leuk Res 1986 0.75
361 Nitric oxide increases leukocyte granule release during simulated extracorporeal circulation. Thorac Cardiovasc Surg 2000 0.75
362 The effect of hyaluronic acid on neutrophil function in vitro and in vivo. Adv Exp Med Biol 1982 0.75
363 Serum myoglobin concentrations are decreased by beta-adrenergic stimulation. Eur J Appl Physiol Occup Physiol 1985 0.75
364 [A rapid troponin T test in acute chest pain. Evaluation in the routine clinical work]. Lakartidningen 1995 0.75
365 Serum ferritin during inflammation. A study on myocardial infarction. Acta Med Scand 1979 0.75
366 Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation. Eur J Cardiothorac Surg 1996 0.75
367 [Uppsala symposium on white blood corpuscles]. Lakartidningen 1978 0.75
368 Soluble adhesion molecules, cytokines and cellular markers in serum in patients with acute infections. Scand J Infect Dis 2001 0.75
369 Prolonged granulocyte activation, as well as hypoxanthine and free radical production after open heart surgery in children. Intensive Care Med 1996 0.75
370 Cationic proteins of human granulocytes Effects on human platelet aggregation and serotonin release. Inflammation 1976 0.75
371 [Hypovolemic shock with edema/hemoconcentration caused by periodic leakage of plasma proteins]. Lakartidningen 1985 0.75
372 Serum levels of lactoferrin and myeloperoxidase in chronic idiopathic and secondary neutropenia. A preliminary report. Scand J Haematol 1986 0.75
373 The effect of IL-5 treatment on the stimulation-induced phosphorylation of proteins in blood eosinophils. Cytokine 2004 0.75